Exosome Diagnostics
John Lagorio is a skilled laboratory professional with extensive experience in molecular diagnostics and patient sample testing. Currently serving as a Senior Laboratory Technologist at Exosome Diagnostics, John utilizes RT-PCR and qPCR techniques while overseeing reagent production and quality control. Prior roles include Clinical Laboratory Technologist at Mayo Clinic Rochester, where John contributed to the development of COVID-19 assays, and earlier experience as a Pharmacy Technician at CVS/pharmacy. Academically, John holds a Bachelor of Science in Biology from the University of Minnesota and a Master of Business Administration from Saint Mary's University of Minnesota, complemented by leadership and organizational roles during university studies and community involvement.
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.